Author Affiliations: Department of Health Systems Administration, Georgetown University School of Nursing and Health Studies (Mr Kraemer) and O’Neill Institute for National and Global Health Law, Georgetown University (Messrs Kraemer and Gostin), Washington, DC.
On February 22, 2011, the US Supreme Court decided Bruesewitz v Wyeth LLC,1 holding that the National Childhood Vaccine Injury Act of 1986 (NCVIA) preempts all design defect claims against vaccine manufacturers in which the plaintiff seeks compensation for injury or death caused by a vaccine's adverse effects. The public health implications are profound because Congress designed the NCVIA to safeguard a social compact—ensuring access to vaccines by preventing the uncertainty of litigation, while also ensuring vaccine safety and effectiveness.
Kraemer JD, Gostin LO. Vaccine Liability in the Supreme CourtForging a Social Compact. JAMA. 2011;305(18):1900–1901. doi:10.1001/jama.2011.615
* * SCHEDULED MAINTENANCE * *
The JAMA Network Sites will be conducting routine maintenance from 10/20/2017 through 10/21/2017. During this window access to content and authentication may be intermittently available. The JAMA Store will be completely unavailable during the maintenance window.